LMP1-mediated glycolysis regulates IL-1β, IL-6, and GM-CSF expression through the NLRP3 inflammatory body, COX-2, and NF-kB signalling pathways, which enhances the expansion of tumor-related bone marrow-derived suppressor cells (MDSCs) (138). The gene discussed is NFKB1; the disease is neoplasm.